Product catalog antigen listed by alphabetic starting with E
| Items 401 to 500 of 628 total | 7 Page(s): |
Protein
| Catalog No. | Species | Presentation | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| H00002045-Q01-10 | EPHA7 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002045-Q01-25 | EPHA7 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002048-Q01-10 | EPHB2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002048-Q01-25 | EPHB2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002049-Q01-10 | EPHB3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002049-Q01-25 | EPHB3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002050-Q01-10 | EPHB4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002050-Q01-25 | EPHB4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002051-Q01-10 | EPHB6 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002051-Q01-25 | EPHB6 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001942-Q01-10 | Ephrin-A1 / EFNA1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001942-Q01-25 | Ephrin-A1 / EFNA1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001944-P01-10 | Ephrin-A3 / EFNA3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001944-P01-25 | Ephrin-A3 / EFNA3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001944-Q01-10 | Ephrin-A3 / EFNA3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001944-Q01-25 | Ephrin-A3 / EFNA3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001946-Q01-10 | Ephrin-A5 / EFNA5 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001946-Q01-25 | Ephrin-A5 / EFNA5 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001947-Q01-10 | Ephrin-B1 / EFNB1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001947-Q01-25 | Ephrin-B1 / EFNB1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001948-Q01-10 | Ephrin-B2 / EFNB2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001948-Q01-25 | Ephrin-B2 / EFNB2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA051 | Epidermal Growth Factor (EGF) antigen | ||||||
| Human | >98% | E. coli | 0.1 mg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA051X | Epidermal Growth Factor (EGF) antigen | ||||||
| Human | >98% | E. coli | 0.5 mg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA1012 | Epidermal Growth Factor (EGF) antigen | ||||||
| Human | Purified | >98% | Pichia pastoris | 0.1 mg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| PA1012X | Epidermal Growth Factor (EGF) antigen | ||||||
| Human | Purified | >98% | Pichia pastoris | 0.5 mg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1012XC | Epidermal Growth Factor (EGF) antigen | ||||||
| Human | Purified | >98% | Pichia pastoris | 1 mg / US$ 455 | |||
| Acris Antibodies GmbH | |||||||
| PA155 | Epidermal Growth Factor (EGF) antigen | ||||||
| Mouse | >98% | E. coli | 0.1 mg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA155X | Epidermal Growth Factor (EGF) antigen | ||||||
| Mouse | >98% | E. coli | 0.5 mg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| 36001P-100 | Epidermal Growth Factor (EGF) antigen | ||||||
| Human | >98% | E. coli | 0.1 mg / --- | ||||
| QED Bioscience Inc. | |||||||
| 36001P-1000 | Epidermal Growth Factor (EGF) antigen | ||||||
| Human | >98% | E. coli | 1 mg / --- | ||||
| QED Bioscience Inc. | |||||||
| 36001P-500 | Epidermal Growth Factor (EGF) antigen | ||||||
| Human | >98% | E. coli | 0.5 mg / --- | ||||
| QED Bioscience Inc. | |||||||
| VTI-880 | Epidermal Growth Factor (EGF) antigen | ||||||
| Human | Purified | >95% | Pichia pastoris | 0.1 mg / ask | |||
| Vybion Inc. | |||||||
| VTI-880X | Epidermal Growth Factor (EGF) antigen | ||||||
| Human | Purified | >95% | Pichia pastoris | 1 mg / ask | |||
| Vybion Inc. | |||||||
| PR15005CF-1000 | Epidermal Growth Factor (EGF), carrier free antigen | ||||||
| Human | Purified | >97% | E. coli | 1 mg / --- | |||
| Neuromics Antibodies | |||||||
| PR15005CF-200 | Epidermal Growth Factor (EGF), carrier free antigen | ||||||
| Human | Purified | >97% | E. coli | 0.2 mg / --- | |||
| Neuromics Antibodies | |||||||
| H00059344-Q01-10 | Epidermis-type lipoxygenase 3 / ALOXE3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00059344-Q01-25 | Epidermis-type lipoxygenase 3 / ALOXE3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| AR01017PU-N | Epigen (EPGN) antigen | ||||||
| Human | Purified | >98% | E. coli | 25 µg / US$ 355 | |||
| Acris Antibodies GmbH | |||||||
| AR01017PU-S | Epigen (EPGN) antigen | ||||||
| Human | Purified | >98% | E. coli | 5 µg / US$ 255 | |||
| Acris Antibodies GmbH | |||||||
| H00002069-Q01-10 | Epiregulin (EREG) antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002069-Q01-25 | Epiregulin (EREG) antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| AR01012PU-N | Epiregulin (EREG) antigen | ||||||
| Human | Purified | >98% | E. coli | 25 µg / US$ 355 | |||
| Acris Antibodies GmbH | |||||||
| AR01012PU-S | Epiregulin (EREG) antigen | ||||||
| Human | Purified | >98% | E. coli | 5 µg / US$ 255 | |||
| Acris Antibodies GmbH | |||||||
| H00002012-P01-02 | Epithelial membrane protein 1 (EMP1) antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002012-P01-10 | Epithelial membrane protein 1 (EMP1) antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002012-P01-25 | Epithelial membrane protein 1 (EMP1) antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002014-P01-10 | Epithelial membrane protein 3 / EMP3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002014-P01-25 | Epithelial membrane protein 3 / EMP3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002014-Q01-10 | Epithelial membrane protein 3 / EMP3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002014-Q01-25 | Epithelial membrane protein 3 / EMP3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009852-Q01-10 | EPM2AIP1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009852-Q01-25 | EPM2AIP1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002052-Q01-10 | Epoxide hydrolase 1 (EPHX1) antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002052-Q01-25 | Epoxide hydrolase 1 (EPHX1) antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| 10-288-22201F | Epoxide hydrolase 1 (EPHX1) antigen | ||||||
| Human | Purified | 90% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22201F-50 | Epoxide hydrolase 1 (EPHX1) antigen | ||||||
| Human | Purified | 90% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| H00002053-Q01-10 | Epoxide hydrolase 2 / EPHX2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002053-Q01-25 | Epoxide hydrolase 2 / EPHX2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00057119-Q01-10 | Eppin antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00057119-Q01-25 | Eppin antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00054869-Q01-10 | EPS8L1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00054869-Q01-25 | EPS8L1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00064787-Q01-10 | EPS8L2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00064787-Q01-25 | EPS8L2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00022905-Q01-10 | Epsin-2 / EPN2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00022905-Q01-25 | Epsin-2 / EPN2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055040-Q01-10 | Epsin-3 / EPN3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055040-Q01-25 | Epsin-3 / EPN3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| BIN132 | Epstein Barr Virus (EBV) Capsid Antigen (VCA gp125) | ||||||
| Aff - Purified | - | P3H3 cells | 1 ml / US$ 405 | ||||
| Acris Antibodies GmbH | |||||||
| BIN038 | Epstein-Barr nuclear antigen 1 / EBNA1 | ||||||
| Purified | - | SF9 cells | 1 ml / US$ 445 | ||||
| Acris Antibodies GmbH | |||||||
| AR00046PU-N | Epstein-Barr Virus (EBV)(HHV-4) Early Antigen D (EA-D) | ||||||
| Purified | E. coli | 1 mg / ask | |||||
| Acris Antibodies GmbH | |||||||
| AR00047PU-N | Epstein-Barr Virus (EBV)(HHV-4) p23 antigen | ||||||
| Purified | E. coli | 1 mg / US$ 685 | |||||
| Acris Antibodies GmbH | |||||||
| AR00048PU-N | Epstein-Barr Virus (EBV-VCA) Viral Capsid Antigen gp125 | ||||||
| Aff - Purified | P3H3 cells | 1 ml / ask | |||||
| Acris Antibodies GmbH | |||||||
| 8EB77 | Epstein-Barr virus, capsid antigen (EBV CA) | ||||||
| >90% | P3HR1 cells | 1 mg / --- | |||||
| HyTest Ltd. | |||||||
| H00094240-Q01-10 | EPSTI1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00094240-Q01-25 | EPSTI1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA1289 | Eptifibatide antigen | ||||||
| Human | Purified | >95% | Synthetic | 5 mg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| PA1289X | Eptifibatide antigen | ||||||
| Human | Purified | >95% | Synthetic | 25 mg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1289XC | Eptifibatide antigen | ||||||
| Human | Purified | >95% | Synthetic | 100 mg / US$ 585 | |||
| Acris Antibodies GmbH | |||||||
| H00011015-P01-10 | ER lumen protein retaining receptor 3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011015-P01-25 | ER lumen protein retaining receptor 3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026284-P01-10 | ERAL1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026284-P01-25 | ERAL1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051752-Q01-10 | ERAP1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051752-Q01-25 | ERAP1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002067-Q01-10 | ERCC1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002067-Q01-25 | ERCC1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002068-P01-10 | ERCC2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002068-P01-25 | ERCC2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002068-Q01-10 | ERCC2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002068-Q01-25 | ERCC2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002071-Q01-10 | ERCC3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002071-Q01-25 | ERCC3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002078-P01-10 | ERG antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002078-P01-25 | ERG antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002078-Q01-10 | ERG antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002078-Q01-25 | ERG antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00114625-Q01-10 | ERMAP antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00114625-Q01-25 | ERMAP antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002081-Q01-10 | ERN1 / IRE1 alpha antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| Items 401 to 500 of 628 total | 7 Page(s): |



